Background illustration for clinical trials search

Paid Clinical Trials Washington, D.C.

Discover 764 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)

for
End Stage Renal Disease
Location: Washington DC, Charlotte NC, Cincinnati OH,
Sponsor: Rockwell Medical Technologies, Inc.

Sex: All

Age: 0 - 17

Code: NCT04239391

Phase3, Recruiting
Active & Responsive

Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

for
Malignant Peripheral Nerve Sheath Tumor (MPNST),
Location: Washington D.C. DC, Dallas TX
Sponsor: AeRang Kim

Sex: All

Age: 18+

Code: NCT06735820

Phase1, Phase2, Recruiting
Active & Responsive

A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

for
Dravet Syndrome
Location: Washington D.C. DC, Charlottesville VA, New York NY,
Sponsor: Stoke Therapeutics, Inc

Sex: All

Age: 2 - 17

Code: NCT06872125

Phase3, Recruiting
Active & Responsive

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

for
Single Ventricle Heart Disease
Location: Washington D.C. DC, Wilmington DE, Philadelphia PA,
Sponsor: Mezzion Pharma Co. Ltd

Sex: All

Age: 12 - 18

Code: NCT05918211

Phase3, Recruiting
Active & Responsive

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

for
Pleuropulmonary Blastoma
Location: Washington D.C. DC, Baltimore MD, Charlottesville VA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT06647953

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering

for
Scoliosis Idiopathic
Location: Washington DC, Philadelphia PA, New York NY,
Sponsor: Pediatric Spine Foundation

Sex: All

Age: 0 - 18

Code: NCT04914507

Recruiting
Active & Responsive

F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors)

for
Oral Mucositis, Periodontal Diseases, Cancer
Location: Washington D.C. DC
Sponsor: Georgetown University

Sex: All

Age: 25 - 70+

Code: NCT06315855

Recruiting
Active & Responsive

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

for
HER2-positive Metastatic Breast Cancer
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT06551116

Recruiting
Active & Responsive

NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors

for
Solid Tumor, KRAS Mutation-Related Tumors
Location: Washington D.C. DC
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT05661201

Phase1, Recruiting
Active & Responsive

Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors

for
Insomnia
Location: Washington D.C. DC
Sponsor: Georgetown University

Sex: Male

Age: 21+

Code: NCT07128927

Recruiting
Active & Responsive

Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer

for
Thyroid Cancer
Location: Washington D.C. DC, Falls Church VA
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT06980103

Recruiting
Active & Responsive

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Washington D.C. DC, Fairfax VA, New York NY,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07111520

Phase1, Phase2, Recruiting
Active & Responsive

CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

for
Hereditary Breast and Ovarian Cancer
Location: Washington D.C. DC, Richmond VA
Sponsor: Georgetown University

Sex: Female

Age: 18+

Code: NCT05130606

Recruiting
Active & Responsive

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT06901531

Phase3, Recruiting
Active & Responsive

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

for
Immune Thrombocytopenic Purpura (ITP)
Location: Washington D.C. DC, Bethesda MD, Philadelphia PA,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06722235

Phase3, Recruiting
Active & Responsive

Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer

for
Carcinoma, Non-Small Cell Lung
Location: Washington D.C. DC, Baltimore MD
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT04499053

Phase2, Recruiting
Active & Responsive

RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer

for
Cancer Related Cognitive Decline, Non-metastatic Breast Cancer
Location: Washington D.C. DC, Hackensack NJ
Sponsor: Georgetown University

Sex: Female

Age: 18+

Code: NCT05256745

Phase1, Phase2, Recruiting
Active & Responsive

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Location: Washington D.C. DC, Baltimore MD, Martinsburg WV,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07198074

Phase3, Recruiting
Active & Responsive

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Washington D.C. DC, Columbia MD, Glen Burnie MD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT04671667

Phase2, Recruiting
Active & Responsive

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

for
Triple Negative Breast Neoplasms
Location: Washington D.C. DC, Silver Spring MD, Clinton MD,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06841354

Phase3, Recruiting